0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Veterinary Vaccine Adjuvants - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: March 2024
|
Report Code: QYRE-Auto-4Y9119
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Veterinary Vaccine Adjuvants Market Outlook 2022
BUY CHAPTERS

Veterinary Vaccine Adjuvants - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-4Y9119
Report
March 2024
Pages:99
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Veterinary Vaccine Adjuvants - Market Size

The global market for Veterinary Vaccine Adjuvants was estimated to be worth US$ 303.7 million in 2023 and is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 6.9% during the forecast period 2024-2030

Veterinary Vaccine Adjuvants - Market

Veterinary Vaccine Adjuvants - Market

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
Global 5 largest manufacturers of Veterinary Vaccine Adjuvants are SEPPIC, Croda, Vertellus, SPI Pharma and SDA BIO, which make up about 70%. Among them, SEPPIC is the leader with about 35% market share.
North America is the largest market, with a share over 30%, followed by Asia-Pacific and Europe, with the share about 30% and 22%. In terms of product type, Emulsion Adjuvants occupy the largest share of the total market, about 58%. And in terms of application, the largest application is Livestock Vaccines, followed by Companion Animals Vaccines.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Veterinary Vaccine Adjuvants, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Veterinary Vaccine Adjuvants by region & country, by Type, and by Application.
The Veterinary Vaccine Adjuvants market size, estimations, and forecasts are provided in terms of sales volume (K L) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Vaccine Adjuvants.
Market Segmentation

Scope of Veterinary Vaccine Adjuvants - Market Report

Report Metric Details
Report Name Veterinary Vaccine Adjuvants - Market
Forecasted market size in 2030 US$ 485.1 million
CAGR 6.9%
Forecasted years 2024 - 2030
Segment by Type:
  • Emulsion Adjuvants
  • Mineral Adjuvants
  • Others
Segment by Application
  • Livestock Vaccines
  • Companion Animals Vaccines
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company SEPPIC, SDA BIO, Croda, SPI Pharma, Phibro Animal Health, Vertellus
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Veterinary Vaccine Adjuvants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Veterinary Vaccine Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Veterinary Vaccine Adjuvants in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Veterinary Vaccine Adjuvants - Market size in 2030?

Ans: The Veterinary Vaccine Adjuvants - Market size in 2030 will be US$ 485.1 million.

What is the SEPPIC, Croda, Vertellus, SPI Pharma, SDA BIO share in Veterinary Vaccine Adjuvants - Market?

Ans: Global 5 largest manufacturers of Veterinary Vaccine Adjuvants are SEPPIC, Croda, Vertellus, SPI Pharma and SDA BIO, which make up about 70%.

What is the SEPPIC share in Veterinary Vaccine Adjuvants - Market?

Ans: Among them, SEPPIC is the leader with about 35% market share.

What is the Veterinary Vaccine Adjuvants - Market share by region?

Ans: North America is the largest market, with a share over 30%, followed by Asia-Pacific and Europe, with the share about 30% and 22%.

What is the Veterinary Vaccine Adjuvants - Market share by type?

Ans: In terms of product type, Emulsion Adjuvants occupy the largest share of the total market, about 58%.

Who are the main players in the Veterinary Vaccine Adjuvants - Market report?

Ans: The main players in the Veterinary Vaccine Adjuvants - Market are SEPPIC, SDA BIO, Croda, SPI Pharma, Phibro Animal Health, Vertellus

What are the Application segmentation covered in the Veterinary Vaccine Adjuvants - Market report?

Ans: The Applications covered in the Veterinary Vaccine Adjuvants - Market report are Livestock Vaccines, Companion Animals Vaccines

What are the Type segmentation covered in the Veterinary Vaccine Adjuvants - Market report?

Ans: The Types covered in the Veterinary Vaccine Adjuvants - Market report are Emulsion Adjuvants, Mineral Adjuvants, Others

1 Market Overview
1.1 Veterinary Vaccine Adjuvants Product Introduction
1.2 Global Veterinary Vaccine Adjuvants Market Size Forecast
1.2.1 Global Veterinary Vaccine Adjuvants Sales Value (2019-2030)
1.2.2 Global Veterinary Vaccine Adjuvants Sales Volume (2019-2030)
1.2.3 Global Veterinary Vaccine Adjuvants Sales Price (2019-2030)
1.3 Veterinary Vaccine Adjuvants Market Trends & Drivers
1.3.1 Veterinary Vaccine Adjuvants Industry Trends
1.3.2 Veterinary Vaccine Adjuvants Market Drivers & Opportunity
1.3.3 Veterinary Vaccine Adjuvants Market Challenges
1.3.4 Veterinary Vaccine Adjuvants Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Veterinary Vaccine Adjuvants Players Revenue Ranking (2023)
2.2 Global Veterinary Vaccine Adjuvants Revenue by Company (2019-2024)
2.3 Global Veterinary Vaccine Adjuvants Players Sales Volume Ranking (2023)
2.4 Global Veterinary Vaccine Adjuvants Sales Volume by Company Players (2019-2024)
2.5 Global Veterinary Vaccine Adjuvants Average Price by Company (2019-2024)
2.6 Key Manufacturers Veterinary Vaccine Adjuvants Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Veterinary Vaccine Adjuvants Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Veterinary Vaccine Adjuvants
2.9 Veterinary Vaccine Adjuvants Market Competitive Analysis
2.9.1 Veterinary Vaccine Adjuvants Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Veterinary Vaccine Adjuvants Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccine Adjuvants as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Emulsion Adjuvants
3.1.2 Mineral Adjuvants
3.1.3 Others
3.2 Global Veterinary Vaccine Adjuvants Sales Value by Type
3.2.1 Global Veterinary Vaccine Adjuvants Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Veterinary Vaccine Adjuvants Sales Value, by Type (2019-2030)
3.2.3 Global Veterinary Vaccine Adjuvants Sales Value, by Type (%) (2019-2030)
3.3 Global Veterinary Vaccine Adjuvants Sales Volume by Type
3.3.1 Global Veterinary Vaccine Adjuvants Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Veterinary Vaccine Adjuvants Sales Volume, by Type (2019-2030)
3.3.3 Global Veterinary Vaccine Adjuvants Sales Volume, by Type (%) (2019-2030)
3.4 Global Veterinary Vaccine Adjuvants Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Livestock Vaccines
4.1.2 Companion Animals Vaccines
4.2 Global Veterinary Vaccine Adjuvants Sales Value by Application
4.2.1 Global Veterinary Vaccine Adjuvants Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Veterinary Vaccine Adjuvants Sales Value, by Application (2019-2030)
4.2.3 Global Veterinary Vaccine Adjuvants Sales Value, by Application (%) (2019-2030)
4.3 Global Veterinary Vaccine Adjuvants Sales Volume by Application
4.3.1 Global Veterinary Vaccine Adjuvants Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Veterinary Vaccine Adjuvants Sales Volume, by Application (2019-2030)
4.3.3 Global Veterinary Vaccine Adjuvants Sales Volume, by Application (%) (2019-2030)
4.4 Global Veterinary Vaccine Adjuvants Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Veterinary Vaccine Adjuvants Sales Value by Region
5.1.1 Global Veterinary Vaccine Adjuvants Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Veterinary Vaccine Adjuvants Sales Value by Region (2019-2024)
5.1.3 Global Veterinary Vaccine Adjuvants Sales Value by Region (2025-2030)
5.1.4 Global Veterinary Vaccine Adjuvants Sales Value by Region (%), (2019-2030)
5.2 Global Veterinary Vaccine Adjuvants Sales Volume by Region
5.2.1 Global Veterinary Vaccine Adjuvants Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Veterinary Vaccine Adjuvants Sales Volume by Region (2019-2024)
5.2.3 Global Veterinary Vaccine Adjuvants Sales Volume by Region (2025-2030)
5.2.4 Global Veterinary Vaccine Adjuvants Sales Volume by Region (%), (2019-2030)
5.3 Global Veterinary Vaccine Adjuvants Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Veterinary Vaccine Adjuvants Sales Value, 2019-2030
5.4.2 North America Veterinary Vaccine Adjuvants Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Veterinary Vaccine Adjuvants Sales Value, 2019-2030
5.5.2 Europe Veterinary Vaccine Adjuvants Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Veterinary Vaccine Adjuvants Sales Value, 2019-2030
5.6.2 Asia Pacific Veterinary Vaccine Adjuvants Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Veterinary Vaccine Adjuvants Sales Value, 2019-2030
5.7.2 South America Veterinary Vaccine Adjuvants Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Veterinary Vaccine Adjuvants Sales Value, 2019-2030
5.8.2 Middle East & Africa Veterinary Vaccine Adjuvants Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Veterinary Vaccine Adjuvants Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Veterinary Vaccine Adjuvants Sales Value
6.2.1 Key Countries/Regions Veterinary Vaccine Adjuvants Sales Value, 2019-2030
6.2.2 Key Countries/Regions Veterinary Vaccine Adjuvants Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Veterinary Vaccine Adjuvants Sales Value, 2019-2030
6.3.2 United States Veterinary Vaccine Adjuvants Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Veterinary Vaccine Adjuvants Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Veterinary Vaccine Adjuvants Sales Value, 2019-2030
6.4.2 Europe Veterinary Vaccine Adjuvants Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Veterinary Vaccine Adjuvants Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Veterinary Vaccine Adjuvants Sales Value, 2019-2030
6.5.2 China Veterinary Vaccine Adjuvants Sales Value by Type (%), 2023 VS 2030
6.5.3 China Veterinary Vaccine Adjuvants Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Veterinary Vaccine Adjuvants Sales Value, 2019-2030
6.6.2 Japan Veterinary Vaccine Adjuvants Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Veterinary Vaccine Adjuvants Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Veterinary Vaccine Adjuvants Sales Value, 2019-2030
6.7.2 South Korea Veterinary Vaccine Adjuvants Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Veterinary Vaccine Adjuvants Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Veterinary Vaccine Adjuvants Sales Value, 2019-2030
6.8.2 Southeast Asia Veterinary Vaccine Adjuvants Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Veterinary Vaccine Adjuvants Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Veterinary Vaccine Adjuvants Sales Value, 2019-2030
6.9.2 India Veterinary Vaccine Adjuvants Sales Value by Type (%), 2023 VS 2030
6.9.3 India Veterinary Vaccine Adjuvants Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 SEPPIC
7.1.1 SEPPIC Company Information
7.1.2 SEPPIC Introduction and Business Overview
7.1.3 SEPPIC Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.1.4 SEPPIC Veterinary Vaccine Adjuvants Product Offerings
7.1.5 SEPPIC Recent Development
7.2 SDA BIO
7.2.1 SDA BIO Company Information
7.2.2 SDA BIO Introduction and Business Overview
7.2.3 SDA BIO Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.2.4 SDA BIO Veterinary Vaccine Adjuvants Product Offerings
7.2.5 SDA BIO Recent Development
7.3 Croda
7.3.1 Croda Company Information
7.3.2 Croda Introduction and Business Overview
7.3.3 Croda Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Croda Veterinary Vaccine Adjuvants Product Offerings
7.3.5 Croda Recent Development
7.4 SPI Pharma
7.4.1 SPI Pharma Company Information
7.4.2 SPI Pharma Introduction and Business Overview
7.4.3 SPI Pharma Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.4.4 SPI Pharma Veterinary Vaccine Adjuvants Product Offerings
7.4.5 SPI Pharma Recent Development
7.5 Phibro Animal Health
7.5.1 Phibro Animal Health Company Information
7.5.2 Phibro Animal Health Introduction and Business Overview
7.5.3 Phibro Animal Health Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Phibro Animal Health Veterinary Vaccine Adjuvants Product Offerings
7.5.5 Phibro Animal Health Recent Development
7.6 Vertellus
7.6.1 Vertellus Company Information
7.6.2 Vertellus Introduction and Business Overview
7.6.3 Vertellus Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Vertellus Veterinary Vaccine Adjuvants Product Offerings
7.6.5 Vertellus Recent Development
8 Industry Chain Analysis
8.1 Veterinary Vaccine Adjuvants Industrial Chain
8.2 Veterinary Vaccine Adjuvants Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Veterinary Vaccine Adjuvants Sales Model
8.5.2 Sales Channel
8.5.3 Veterinary Vaccine Adjuvants Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Veterinary Vaccine Adjuvants Market Trends
    Table 2. Veterinary Vaccine Adjuvants Market Drivers & Opportunity
    Table 3. Veterinary Vaccine Adjuvants Market Challenges
    Table 4. Veterinary Vaccine Adjuvants Market Restraints
    Table 5. Global Veterinary Vaccine Adjuvants Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Veterinary Vaccine Adjuvants Revenue Market Share by Company (2019-2024)
    Table 7. Global Veterinary Vaccine Adjuvants Sales Volume by Company (2019-2024) & (K L)
    Table 8. Global Veterinary Vaccine Adjuvants Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Veterinary Vaccine Adjuvants Price by Company (2019-2024) & (USD/L)
    Table 10. Key Manufacturers Veterinary Vaccine Adjuvants Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Veterinary Vaccine Adjuvants Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Veterinary Vaccine Adjuvants
    Table 13. Global Veterinary Vaccine Adjuvants Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccine Adjuvants as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Veterinary Vaccine Adjuvants Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Veterinary Vaccine Adjuvants Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Veterinary Vaccine Adjuvants Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Veterinary Vaccine Adjuvants Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Veterinary Vaccine Adjuvants Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Veterinary Vaccine Adjuvants Sales Volume by Type: 2019 VS 2023 VS 2030 (K L)
    Table 22. Global Veterinary Vaccine Adjuvants Sales Volume by Type (2019-2024) & (K L)
    Table 23. Global Veterinary Vaccine Adjuvants Sales Volume by Type (2025-2030) & (K L)
    Table 24. Global Veterinary Vaccine Adjuvants Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Veterinary Vaccine Adjuvants Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Veterinary Vaccine Adjuvants Price by Type (2019-2024) & (USD/L)
    Table 27. Global Veterinary Vaccine Adjuvants Price by Type (2025-2030) & (USD/L)
    Table 28. Global Veterinary Vaccine Adjuvants Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Veterinary Vaccine Adjuvants Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Veterinary Vaccine Adjuvants Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Veterinary Vaccine Adjuvants Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Veterinary Vaccine Adjuvants Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Veterinary Vaccine Adjuvants Sales Volume by Application: 2019 VS 2023 VS 2030 (K L)
    Table 34. Global Veterinary Vaccine Adjuvants Sales Volume by Application (2019-2024) & (K L)
    Table 35. Global Veterinary Vaccine Adjuvants Sales Volume by Application (2025-2030) & (K L)
    Table 36. Global Veterinary Vaccine Adjuvants Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Veterinary Vaccine Adjuvants Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Veterinary Vaccine Adjuvants Price by Application (2019-2024) & (USD/L)
    Table 39. Global Veterinary Vaccine Adjuvants Price by Application (2025-2030) & (USD/L)
    Table 40. Global Veterinary Vaccine Adjuvants Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Veterinary Vaccine Adjuvants Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Veterinary Vaccine Adjuvants Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Veterinary Vaccine Adjuvants Sales Value by Region (2019-2024) & (%)
    Table 44. Global Veterinary Vaccine Adjuvants Sales Value by Region (2025-2030) & (%)
    Table 45. Global Veterinary Vaccine Adjuvants Sales Volume by Region (K L): 2019 VS 2023 VS 2030
    Table 46. Global Veterinary Vaccine Adjuvants Sales Volume by Region (2019-2024) & (K L)
    Table 47. Global Veterinary Vaccine Adjuvants Sales Volume by Region (2025-2030) & (K L)
    Table 48. Global Veterinary Vaccine Adjuvants Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Veterinary Vaccine Adjuvants Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Veterinary Vaccine Adjuvants Average Price by Region (2019-2024) & (USD/L)
    Table 51. Global Veterinary Vaccine Adjuvants Average Price by Region (2025-2030) & (USD/L)
    Table 52. Key Countries/Regions Veterinary Vaccine Adjuvants Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Veterinary Vaccine Adjuvants Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Veterinary Vaccine Adjuvants Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Veterinary Vaccine Adjuvants Sales Volume, (2019-2024) & (K L)
    Table 56. Key Countries/Regions Veterinary Vaccine Adjuvants Sales Volume, (2025-2030) & (K L)
    Table 57. SEPPIC Company Information
    Table 58. SEPPIC Introduction and Business Overview
    Table 59. SEPPIC Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 60. SEPPIC Veterinary Vaccine Adjuvants Product Offerings
    Table 61. SEPPIC Recent Development
    Table 62. SDA BIO Company Information
    Table 63. SDA BIO Introduction and Business Overview
    Table 64. SDA BIO Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 65. SDA BIO Veterinary Vaccine Adjuvants Product Offerings
    Table 66. SDA BIO Recent Development
    Table 67. Croda Company Information
    Table 68. Croda Introduction and Business Overview
    Table 69. Croda Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 70. Croda Veterinary Vaccine Adjuvants Product Offerings
    Table 71. Croda Recent Development
    Table 72. SPI Pharma Company Information
    Table 73. SPI Pharma Introduction and Business Overview
    Table 74. SPI Pharma Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 75. SPI Pharma Veterinary Vaccine Adjuvants Product Offerings
    Table 76. SPI Pharma Recent Development
    Table 77. Phibro Animal Health Company Information
    Table 78. Phibro Animal Health Introduction and Business Overview
    Table 79. Phibro Animal Health Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 80. Phibro Animal Health Veterinary Vaccine Adjuvants Product Offerings
    Table 81. Phibro Animal Health Recent Development
    Table 82. Vertellus Company Information
    Table 83. Vertellus Introduction and Business Overview
    Table 84. Vertellus Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
    Table 85. Vertellus Veterinary Vaccine Adjuvants Product Offerings
    Table 86. Vertellus Recent Development
    Table 87. Key Raw Materials Lists
    Table 88. Raw Materials Key Suppliers Lists
    Table 89. Veterinary Vaccine Adjuvants Downstream Customers
    Table 90. Veterinary Vaccine Adjuvants Distributors List
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Veterinary Vaccine Adjuvants Product Picture
    Figure 2. Global Veterinary Vaccine Adjuvants Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Veterinary Vaccine Adjuvants Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Veterinary Vaccine Adjuvants Sales Volume (2019-2030) & (K L)
    Figure 5. Global Veterinary Vaccine Adjuvants Sales Price (2019-2030) & (USD/L)
    Figure 6. Veterinary Vaccine Adjuvants Report Years Considered
    Figure 7. Global Veterinary Vaccine Adjuvants Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Veterinary Vaccine Adjuvants Players Sales Volume Ranking (2023) & (K L)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Veterinary Vaccine Adjuvants Revenue in 2023
    Figure 10. Veterinary Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Emulsion Adjuvants Picture
    Figure 12. Mineral Adjuvants Picture
    Figure 13. Others Picture
    Figure 14. Global Veterinary Vaccine Adjuvants Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Veterinary Vaccine Adjuvants Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Veterinary Vaccine Adjuvants Sales Volume by Type (2019 VS 2023 VS 2030) & (K L)
    Figure 17. Global Veterinary Vaccine Adjuvants Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Veterinary Vaccine Adjuvants Price by Type (2019-2030) & (USD/L)
    Figure 19. Product Picture of Livestock Vaccines
    Figure 20. Product Picture of Companion Animals Vaccines
    Figure 21. Global Veterinary Vaccine Adjuvants Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Veterinary Vaccine Adjuvants Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Veterinary Vaccine Adjuvants Sales Volume by Application (2019 VS 2023 VS 2030) & (K L)
    Figure 24. Global Veterinary Vaccine Adjuvants Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Veterinary Vaccine Adjuvants Price by Application (2019-2030) & (USD/L)
    Figure 26. North America Veterinary Vaccine Adjuvants Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Veterinary Vaccine Adjuvants Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Veterinary Vaccine Adjuvants Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Veterinary Vaccine Adjuvants Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Veterinary Vaccine Adjuvants Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Veterinary Vaccine Adjuvants Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Veterinary Vaccine Adjuvants Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Veterinary Vaccine Adjuvants Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Veterinary Vaccine Adjuvants Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Veterinary Vaccine Adjuvants Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Veterinary Vaccine Adjuvants Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Veterinary Vaccine Adjuvants Sales Volume (%), (2019-2030)
    Figure 38. United States Veterinary Vaccine Adjuvants Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Veterinary Vaccine Adjuvants Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Veterinary Vaccine Adjuvants Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Veterinary Vaccine Adjuvants Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Veterinary Vaccine Adjuvants Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Veterinary Vaccine Adjuvants Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Veterinary Vaccine Adjuvants Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Veterinary Vaccine Adjuvants Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Veterinary Vaccine Adjuvants Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Veterinary Vaccine Adjuvants Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Veterinary Vaccine Adjuvants Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Veterinary Vaccine Adjuvants Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Veterinary Vaccine Adjuvants Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Veterinary Vaccine Adjuvants Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Veterinary Vaccine Adjuvants Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Veterinary Vaccine Adjuvants Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Veterinary Vaccine Adjuvants Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Veterinary Vaccine Adjuvants Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Veterinary Vaccine Adjuvants Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Veterinary Vaccine Adjuvants Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Veterinary Vaccine Adjuvants Sales Value by Application (%), 2023 VS 2030
    Figure 59. Veterinary Vaccine Adjuvants Industrial Chain
    Figure 60. Veterinary Vaccine Adjuvants Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS